![]() |
市場調査レポート
商品コード
1433325
血液処理装置・消耗品の世界市場:2023~2030年Global Blood Processing Devices and Consumables Market 2023-2030 |
||||||
カスタマイズ可能
|
血液処理装置・消耗品の世界市場:2023~2030年 |
出版日: 2023年12月08日
発行: Orion Market Research
ページ情報: 英文 160 Pages
納期: 2~3営業日
|
世界の血液処理装置・消耗品市場は、輸血を必要とする疾患の増加、外科手術の増加、高齢者人口の増加により、2023~2030年の予測期間中にCAGR 9.2%で成長すると予測されています。手術やその他の輸血処置のための安全な血液供給に対するニーズの高まりが、市場の成長を示しています。輸血や献血によって引き起こされる感染症を克服するために、いくつかの血液処理装置・消耗品が感染を防ぐために利用されています。
血液処理装置の中でも、血球処理装置のサブセグメントが世界の血液処理装置・消耗品市場でかなりのシェアを占めると予想されています。血液処理装置は、輸血医療分野における貴重な救命処置の一つです。血液処理装置は、全血を主要成分に分離するために遠心分離機ベースの技術を採用しています。血液処理装置は、コニカルチューブを使用した密度勾配分離媒体の上に手作業で血液を重ねるなど、細胞製品を分離するための手間のかかる技術に代わる選択肢を提供します。血液処理装置は、血液バンク、輸血検査室、細胞治療検査室、製造施設で使用されています。献血数の増加と市場参入企業による新製品の投入は、このセグメントの成長を促進する主な要因です。WHOによると、世界では毎年約1億1,850万単位の献血が行われているが、世界の全患者の輸血ニーズを満たすには、さらに多くの単位を集める必要があります。2008年から2018年にかけて、自発的な無報酬ドナーからの献血は1,070万件増加したと報告されています。
世界の血液処理装置・消耗品市場は、北米(米国、カナダ)、欧州(英国、イタリア、スペイン、ドイツ、フランス、その他の欧州)、アジア太平洋(インド、中国、日本、韓国、その他のアジア太平洋)、その他の地域(中東・アフリカ、南米)を含む地域別にさらに区分されます。なかでもアジア太平洋地域は、中国やインドなどの国々におけるヘルスケア支出の増加や、ヘルスケアインフラを改善するための政府の取り組みにより、先進的な血液処理技術や消耗品の採用が進んでいることから、世界全体で大きなシェアを占めると予想されます。
全地域の中でも北米地域は、血液がん患者の増加や、血液処理の必要性を生じさせる血液成分の流通に従事する複数の組織の存在により、予測期間中にかなりのCAGRで成長すると予測されています。骨髄、血液細胞、リンパ節、その他のリンパ系成分はすべて、白血病、リンパ腫、骨髄腫、骨髄異形成症候群(MDS)などのがんによって影響を受ける可能性があります。アフェレシス技術は、他の薬剤で白血球数を調整できるようになるまで、白血球数を低下させるために利用されてきたようです。
白血病リンパ腫協会(LLS)によると、2021年には米国で約3分に1人が血液がんと診断されます。米国では約9分に1人が血液がんで死亡しています。さらに、この地域の組織が市民の間で献血に関する意識の向上に取り組んでいることも、血液処理装置・消耗品市場の需要を促進しています。毎年、米国では推定680万人が献血を行い、1年間に1360万単位の全血と赤血球が回収されています。
Global Blood Processing Devices and Consumables Market Size, Share & Trends Analysis Report by Blood Processing Devices (Blood Bank Freezers, Blood Warmers, Blood Grouping Analyzers, Blood Bank Refrigerators, Hematocrit Centrifuges and Blood Cell Processors), and by Consumables (Blood Lancets, Vials, Microscopic Slides, Blood Bags, Blood Administration Sets, and Others), Forecast Period (2023-2030)
The global blood processing devices and consumables market is anticipated to grow at a CAGR of 9.2% during the forecast period (2023-2030) owing to the rise burden of disorders requiring blood transfusion, increasing surgical procedures, as well as increasing geriatric population. The rising need for safe blood supply for surgeries or other transfusion procedures is shows market growth. To overcome the infections caused due to blood transfusions and blood donation, several blood processing machines and blood processing consumables are utilized to prevent infection.
The global blood processing devices and consumables market is segmented by the blood processing devices, and consumables. Based on the blood processing devices, the market is sub-segmented into blood bank freezers, blood warmers, blood grouping analyzers, blood bank refrigerators, hematocrit centrifuges and blood cell processors. Further, based on consumables, the market is sub-segmented into blood lancets, vials, microscopic slides, blood bags, blood administration sets, and others. Among the consumables, the blood bags sub-segment is anticipated to hold a considerable share of the market due to rising numbers of hospitals, blood banks, and other healthcare centers. Furthermore, the growing awareness about blood donation among citizens is also propelling the demand for blood bags, globally.
Among the blood processing devices, the blood cell processors sub-segment is expected to hold a considerable share of the global Blood Processing Devices and Consumables market. Blood cell processors is one of the precious lifesaving procedures in the field of transfusion medicine. Blood cell processors employs centrifuge-based technology to separate the whole blood into its major components. Blood cell processors provide an option to labor-intensive techniques for separating cell products, such as manually layering blood over a density gradient separation medium using conical tubes. Blood cell processors are used in blood banks, transfusion laboratories, cellular therapy laboratories, and manufacturing facilities. Increasing number of blood donations as well as the introduction of new products by the market players are major factors fueling the growth of the segment. According to WHO, around 118.5 million units of donated blood are collected globally every year, although more units would need to be collected to meet the needs of transfusion of all the patients in the globally. An increase of 10.7 million blood donations from voluntary unpaid donors has been reported from 2008 to 2018.
The global blood processing devices and consumables market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to increasing healthcare expenditure and government initiatives to improve healthcare infrastructure in countries such as China and India drive the adoption of advanced blood processing technologies and consumables.
Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period due to the rising cases blood cancer and presence of several organizations engaged in the distribution of blood components that arises the need for blood processing. Bone marrow, blood cells, lymph nodes, and other lymphatic system components can all be impacted by cancers such as leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS). Apheresis technology has apparently been utilized to lower the white cell count until other drugs are able to regulate it.
According to the Leukemia and Lymphoma Society (LLS), approximately every three minutes, one person in the US is diagnosed with blood cancer in 2021. Approximately every 9 minutes, someone in the US dies from a blood cancer. Moreover, organizations in the region are engaged in growing awareness about blood donation among citizens is also propelling the demand for blood processing devices and consumables market. Each year, an estimated 6.8 million people in the U.S. donate blood and 13.6 million units of whole blood and red blood cells are collected in the U.S. in a year.
The major companies serving the global blood processing devices and consumables market include Abbott Laboratories, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021, BD (Becton, Dickinson and Company), acquired Velano Vascular. The Velano Vascular acquisition is in line with BD's growth strategy to enter new categories that deal with unmet needs and have a more positive impact on patients and health systems. Velano Vascular offers an innovative, needle-free technology that enables high-quality blood drawn from existing peripheral intravenous catheter (PIVC) lines, BD can now enable health care providers to help eliminate multiple needlesticks for blood sample collection, reducing the pain and discomfort from the process while delivering quality outcomes